A study of 80 patients with advanced Stage IV pancreatic cancer in a Phase I/II trial of gemcitabine + nab-paclitaxel + GDC-0449 - Stand Up To Cancer

Blog

Posted October 14, 2019

A study of 80 patients with advanced Stage IV pancreatic cancer in a Phase I/II trial of gemcitabine + nab-paclitaxel + GDC-0449

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.